Siblings 會議論文/會議摘要 [0/1] Collection Statistics 近3年內發表的文件:5(20.83%) 含全文筆數:24(100.00%) 文件下載次數統計 下載大於0次:24(100.00%) 下載大於100次:22(91.67%) 檔案下載總次數:12134(100.00%) 最後更新時間: 2024-11-28 15:44 Top Upload Loading... Top Download Loading... Recent Submissions DBPR116, a prodrug of BPRMU191, in ... Discovery of a mu-opioid receptor m... A dual nociceptin and mu opioid rec... Benzo[b]thiophene-2-carboxamides as... Selective and antagonist-dependent ... Comparative study between deep lear... Increased activation of HDAC1/2/6 a... Betulinic acid-mediated tuning of P... Morphine produces potent antinocice... BPR1M97, a dual mu opioid receptor/...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-10 of 24. (3 Page(s) Totally) 1 2 3 > >> View [10|25|50] records per page

Date	Title	Relation
2024-10-29	DBPR116, a prodrug of BPRMU191, in combination with naltrexone as a safer opioid analgesic than morphine via peripheral administration	Journal of Medicinal Chemistry. 2024 Oct 29;Article in Press.
2024-07-17	Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesia	Cell Chemical Biology. 2024 Jul 17;Article in Press.
2023-10-05	A dual nociceptin and mu opioid receptor agonist exhibited robust antinociceptive effect with decreased side effects	European Journal of Medicinal Chemistry. 2023 Oct 05;258:Article number 115608.
2022-12-05	Benzo[b]thiophene-2-carboxamides as novel opioid receptor agonists with potent analgesic effect and reduced constipation	European Journal of Medicinal Chemistry. 2022 Dec 5;243:Article number 114728.
2022-11	Selective and antagonist-dependent µ-opioid receptor activation by the combination of 2-{[2-(6-chloro-3,4-dihydro-1(2H)-quinolinyl)-2-oxoethyl]sulfanyl}-5-phenyl-4,6-(1H,5H)-pyrimidinedione and naloxone/naltrexone	Bioorganic Chemistry. 2022 Nov;128:Article number 105905.
2020-10-08	Comparative study between deep learning and QSAR classifications for TNBC inhibitors and novel GPCR agonist discovery	Scientific Reports. 2020 Oct 8;10:Article number 16771.
2020-10	Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma	Neuro-Oncology. 2020 Oct;22(10):1439-1451.
2020-06	Morphine produces potent antinociception, sedation, and hypothermia in humanized mice expressing human mu opioid receptor splice variants	Pain. 2020 Jun;161(6):1177-1190.
2020-04-15	Betulinic acid-mediated tuning of PERK/CHOP signaling by Sp1 inhibition as a novel therapeutic strategy for glioblastoma	Cancers. 2020 Apr 15;12(4):Article number 981.
2020-04	BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine	Neuropharmacology. 2020 Apr;166:Article number 107678.

Showing items 1-10 of 24. (3 Page(s) Totally) 1 2 3 > >> View [10|25|50] records per page